Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

FDA panel backs GSK RSV vaccine ahead of approval

March 2, 2023 Medical Communications

Yesterday, GSK shared that an advisory committee from the FDA voted in support of its respiratory syncytial virus (RSV) vaccine …
News

NICE recommends more digital mental health therapies for NHS use

March 1, 2023 Medical Communications

Eight more digital therapies (DTx) for mental health disorders have been recommended by NICE for use by the NHS, following …
News

FDA approves Reata Pharmaceuticals’ first-in-class treatment for Friedreich’s Ataxia

March 1, 2023 Medical Communications

US-based Reata Pharmaceuticals has announced that its first-in-class treatment for Friedreich’s Ataxia (FA), Skyclarys, has been given FDA approval. This …
News

Johnson & Johnson’s Janssen-Cilag unit gets disappointing ‘restricted’ label for PARP drug in EU

February 28, 2023 Medical Communications

Johnson & Johnson (J&J)’s Janssen-Cilag unit has announced that its fixed-dose combination drug Akeega has been recommended for approval by …
News

MHRA’s authority restored following Northern Ireland Brexit deal

February 28, 2023 Medical Communications

The Medicines and Healthcare products Regulatory Agency (MHRA) has been limited to approving medicines in Great Britain (England, Scotland and …
News

FDA sued by US states over abortion pill access

February 27, 2023 Medical Communications

Attorneys general (AGs) from 12 Democrat-led US states have made complaints to the FDA in an attempt to force the …
News

Causeway Therapeutics raises £8.75m for tennis elbow research

February 27, 2023 Medical Communications

University of Glasgow spin-out Causeway Therapeutics has announced that it has raised £8.75m from investors, which will fund an international …
News

AbbVie gains positive CHMP opinion for upadacitinib for the treatment of Crohn’s disease

February 27, 2023 Medical Communications

AbbVie has announced that it has received positive feedback from the EMA’s Committee for Medicinal Products for Human Use (CHMP) …
News

Merck to appeal EU rejection of COVID-19 drug

February 27, 2023 Medical Communications

Life science giant Merck & Co has announced that it will appeal the EU’s Committee for Medicinal Products for Human …
News

Sanofi and Glooko partner on ‘connected insulin’ tech

February 24, 2023 Medical Communications

Big pharma company Sanofi aims to develop insulin-based therapies that can be connected with glucose monitoring devices, making it easier …
News

Mologic Inc’s COVID-19 rapid antigen self-test receives FDA Emergency Use Authorization for home use

February 24, 2023 Medical Communications

US subsidiary of Global Access Diagnostics (GADx) ‒ a developer of lateral flow and rapid diagnostic technologies, products and services …
News

NICE approved BMS’s Opdivo for lung cancer

February 24, 2023 Medical Communications

Bristol-Myers Squibb’s (BMS) immunotherapy drug Opdivo (nivolumab) has become the first to be cleared for NHS use alongside chemotherapy as …
News

Moda Living and LloydsPharmacy partner to offer residents prescription service

February 24, 2023 Medical Communications

Moda Living has announced a partnership with LloydsPharmacy to bring residents a ‘Health Concierge Service’ through VideoGP.   VideoGP will …
News

AstraZeneca signs $63m agreement for gastric cancer treatment

February 23, 2023 Medical Communications

AstraZeneca has announced that it has signed an exclusive license agreement (ELA) with KYM Biosciences Inc for CMG901, which is …
News

£1.6bn of research and development funding “surrendered” back to UK Treasury

February 23, 2023 Medical Communications

A pot of £1.6bn which was originally allocated as the UK’s contribution to the €96bn Horizon Europe research funding programme …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026